Annual report pursuant to Section 13 and 15(d)

SELECTED FINANCIAL STATEMENT LIABILITIES (Details)

v3.22.1
SELECTED FINANCIAL STATEMENT LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Accounts payable:    
Clinical and regulatory expenses $ 534 $ 262
Professional fees 477 252
Selling expenses 932 395
Manufacturing cost 378 596
Other vendors 262 518
Total accounts payable 2,583 2,023
Accrued interest payable, related parties 91 41
Accrued interest payable 579 627
Accrued expenses:    
Payroll expenses 1,097 1,053
Government rebates and other rebates 4,371 2,659
Due to equity method investee   545
Other accrued expenses 468 512
Total accrued expenses 5,936 4,769
Total accounts payable and accrued expenses $ 9,189 $ 7,460